PHF20L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.458800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.301800E-01
Normal-vs-Stage2
5.701400E-01
Normal-vs-Stage3
8.600500E-02
Normal-vs-Stage4
9.094600E-01
Stage1-vs-Stage2
9.485800E-01
Stage1-vs-Stage3
1.035180E-01
Stage1-vs-Stage4
5.613200E-01
Stage2-vs-Stage3
1.907430E-01
Stage2-vs-Stage4
3.828000E-01
Stage3-vs-Stage4
2.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.370200E-01
Normal-vs-AfricanAmerican
5.349400E-01
Normal-vs-Asian
4.891600E-01
Caucasian-vs-AfricanAmerican
8.670800E-01
Caucasian-vs-Asian
6.096600E-01
AfricanAmerican-vs-Asian
8.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.514800E-01
Normal-vs-Female
5.630600E-01
Male-vs-Female
8.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.579200E-01
Normal-vs-Age(41-60Yrs)
9.849200E-01
Normal-vs-Age(61-80Yrs)
3.510400E-01
Normal-vs-Age(81-100Yrs)
3.175600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.807600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.121200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.760600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.017300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.051790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.626400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.970600E-01
Normal-vs-Daily Drinker
3.159000E-01
Normal-vs-Weekly Drinker
3.289200E-01
Normal-vs-Occasional Drinker
8.309400E-01
Normal-vs-Social Drinker
7.442800E-01
Non Drinker-vs-Daily Drinker
8.775800E-01
Non Drinker-vs-Weekly Drinker
9.486200E-01
Non Drinker-vs-Occasional Drinker
4.308100E-02
Non Drinker-vs-Social Drinker
3.291600E-01
Daily Drinker-vs-Weekly Drinker
8.337800E-01
Daily Drinker-vs-Occasional Drinker
3.564200E-02
Daily Drinker-vs-Social Drinker
2.635200E-01
Weekly Drinker-vs-Occasional Drinker
8.332000E-02
Weekly Drinker-vs-Social Drinker
3.846800E-01
Occasional Drinker-vs-Social Drinker
3.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.304400E-01
Normal-vs-Grade 2
1.160040E-01
Normal-vs-Grade 3
1.047780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.671000E-01
Grade 1-vs-Grade 3
9.011600E-02
Grade 1-vs-Grade 4
2.304400E-01
Grade 2-vs-Grade 3
6.554200E-02
Grade 2-vs-Grade 4
1.160040E-01
Grade 3-vs-Grade 4
1.047780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.422800E-01
Normal-vs-NonDiabetic
5.415400E-01
Diabetic-vs-NonDiabetic
2.699200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.332430E-01
Normal-vs-NoPancreatitis
5.327600E-01
Pancreatitis-vs-NoPancreatitis
3.715200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.771000E-01
Normal-vs-N1
5.854400E-01
N0-vs-N1
5.357400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.990400E-01
Normal-vs-TP53-NonMutant
4.475600E-01
TP53-Mutant-vs-TP53-NonMutant
1.805970E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
